Pregnancy and primary pulmonary hypertension - Successful outcome with epoprostenol therapy

被引：65

作者：

Stewart, R

Tuazon, D

Olson, G

Duarte, AG

机构：

[1] Univ Texas, Med Branch, Dept Internal Med, Div Pulm & Crit Care Med, Galveston, TX 77555 USA

[2] Univ Texas, Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA

来源：

CHEST | 2001年 / 119卷 / 03期

关键词：

cesarean section; epoprostenol; pulmonary hypertension; pregnancy;

D O I：

10.1378/chest.119.3.973

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Primary pulmonary hypertension (PPH) associated with pregnancy carries a high maternal mortality rate. Short-term epoprostenol infusion has been demonstrated to improve the hemodynamic profile in patients with PPH. We report a successful maternal-fetal outcome with epoprostenol therapy during pregnancy, cesarean section, and postpartum in a patient with PPH. Epoprostenol therapy did not produce any physical or developmental abnormalities in the fetus. A favorable maternal-fetal outcome may. occur with a multidisciplinary approach.

引用

页码：973 / 975

页数：3

共 12 条

[1]

[Anonymous], CARDIAC PROBLEMS PRE

[2]

Badalian SS, 2000, J REPROD MED, V45, P149

[3] Pulmonary hypertension in pregnancy: Treatment with pulmonary vasodilators [J].